Vitamin D, immunity and lupus

被引:127
作者
Cutolo, M. [1 ,2 ]
Otsa, K. [3 ]
机构
[1] Univ Genoa, Res Lab, Dept Internal Med, I-16132 Genoa, Italy
[2] Univ Genoa, Acad Clin Unit Rheumatol, Dept Internal Med, I-16132 Genoa, Italy
[3] Tallinn Cent Hosp, Dept Rheumatol, Tallinn, Estonia
关键词
immune response; systemic lupus erythematosus; vitamin D;
D O I
10.1177/0961203307085879
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The identification of vitamin D receptor in cells involved in the immune response and the discovery that activated dendritic cells produce vitamin D hormone suggested that vitamin D could exert immunoregulatory effects. Patients with autoimmune diseases such as multiple sclerosis, rheumatoid arthritis and systemic lupus erythematosus (SLE) show low 25-OH vitamin D serum levels. In particular, SLE patients have multiple risk factors for vitamin D deficiency and disease severity seems correlated with lower 25-OH vitamin D serum levels. Treatment of vitamin D deficiency could be particularly important in SLE patients due to concomitant insults on their tissues such as bone, and in view of the possible immunomodulatory effects exerted by vitamin D. Lupus (2008) 17, 6-10.
引用
收藏
页码:6 / 10
页数:5
相关论文
共 43 条
  • [31] Mattner F, 2000, EUR J IMMUNOL, V30, P498, DOI 10.1002/1521-4141(200002)30:2<498::AID-IMMU498>3.0.CO
  • [32] 2-Q
  • [33] Vitamin D intake is inversely associated with rheumatoid arthritis - Results from the Iowa Women's Health Study
    Merlino, LA
    Curtis, J
    Mikuls, TR
    Cerhan, JR
    Criswell, LA
    Saag, KG
    [J]. ARTHRITIS AND RHEUMATISM, 2004, 50 (01): : 72 - 77
  • [34] VITAMIN-D-3 METABOLISM IN PATIENTS WITH RHEUMATIC DISEASES - LOW SERUM LEVELS OF 25-HYDROXYVITAMIN D-3 IN PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS
    MULLER, K
    KRIEGBAUM, NJ
    BASLUND, B
    SORENSEN, OH
    THYMANN, M
    BENTZEN, K
    [J]. CLINICAL RHEUMATOLOGY, 1995, 14 (04) : 397 - 400
  • [35] Vitamin D intake and incidence of multiple sclerosis
    Munger, KL
    Zhang, SM
    O'Reilly, E
    Hernán, MA
    Olek, MJ
    Willett, WC
    Ascherio, A
    [J]. NEUROLOGY, 2004, 62 (01) : 60 - 65
  • [36] THE EFFECTS OF CHLOROQUINE ON SERUM 1,25-DIHYDROXYVITAMIN-D AND CALCIUM-METABOLISM IN SARCOIDOSIS
    OLEARY, TJ
    JONES, G
    YIP, A
    LOHNES, D
    COHANIM, M
    YENDT, ER
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1986, 315 (12) : 727 - 730
  • [37] REDUCED SERUM 1,25-(OH)2 VITAMIN-D3 LEVELS IN PREDNISONE-TREATED ADOLESCENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS
    OREGAN, S
    CHESNEY, RW
    HAMSTRA, A
    EISMAN, JA
    OGORMAN, AM
    DELUCA, HF
    [J]. ACTA PAEDIATRICA SCANDINAVICA, 1979, 68 (01): : 109 - 111
  • [38] 1α,25-dihydroxyvitamin D3 inhibits differentiation, maturation, activation, and survival of dendritic cells leading to impaired alloreactive T cell activation
    Penna, G
    Adorini, L
    [J]. JOURNAL OF IMMUNOLOGY, 2000, 164 (05) : 2405 - 2411
  • [39] Bone mineral density and biochemical parameters of bone metabolism in female patients with systemic lupus erythematosus
    Redlich, K
    Ziegler, S
    Kiener, HP
    Spitzauer, S
    Stohlawetz, P
    Bernecker, P
    Kainberger, F
    Grampp, S
    Kudlacek, S
    Woloszczuk, W
    Smolen, JS
    Pietschmann, P
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2000, 59 (04) : 308 - 310
  • [40] 1,25-dihydroxyvitamin D3 inhibits IFN-γ and IL-4 levels during in vitro polarization of primary murine CD4+ T cells
    Staeva-Vieira, TP
    Freedman, LP
    [J]. JOURNAL OF IMMUNOLOGY, 2002, 168 (03) : 1181 - 1189